About us
We develop new platform technologies to more effectively diagnose and treat cancer. We primarily develop molecular imaging and phototherapy agents as well as nature-inspired theranostic nanomedicines, with a focus on creating clinically translatable technologies.
In collab with @radnucmp, our post-doc Miffy Cheng @NMIN_NCE showed that texaphrin nanoparticles have theranostic capabilities, stemming from its inherent metal chelation ability. Our particles enabled prostate cancer imaging and therapy! Check it out: https://t.co/UTGmEMiBnQ https://t.co/mmUcfPXRnK
